The firm is widely regarded as a leader in the emerging field of immunotherapy, in which viruses that attack malignant tumours are administered to patients, and has made multiple appearances on lists…
An annual ranking of Canada’s highest-potential private firms welcomes Ottawa’s Assent Compliance and MindBridge Ai to the list in 2019 alongside a couple of familiar faces in the Nationa
One of Ottawa’s most-lauded biotech startups is strengthening its leadership team with several veteran pharmaceutical executives as the company enters “a new phase” of business growth.
Two of Ottawa’s own are among the 50 most financially attractive firms in the country – a list of private companies dubbed “narwhals” by an independent research institute.
An Ottawa biotech startup that is developing groundbreaking cancer-fighting viruses has inked a deal with a U.S. biopharmaceutical firm to market and sell its products.
An Ottawa biotech startup has received a US$41-million injection of venture capital to further develop its groundbreaking treatments that use the body’s own immune system to battle cancer.